• 제목/요약/키워드: lipid metabolic abnormality

검색결과 4건 처리시간 0.018초

담위환(膽胃丸) 투약을 통한 건선환자 치험 3례 - 지질대사이상 증상을 중심으로 (3 Cases Reports of Psoriasis Treated by Damwi-hwan - Focused on Lipid Metabolic Abnomarilty)

  • 조재곤;양윤홍;한수련;조아라
    • 한방안이비인후피부과학회지
    • /
    • 제30권4호
    • /
    • pp.167-175
    • /
    • 2017
  • Objectives : The purpose of this study is to present 3 cases reports of psoriasis treated by Damwi-hwan - focused on lipid metabolic abnomarilty. Methods : We administered Damwi-hwan to three patients who showed psoriasis with lipid metabolic abnormality and evaluated the results by Psoriasis Area and Severity Index(PASI). Results : After the treatment three patients showed improvements in PASI. PASI of patient 1 changed from 15.4 to 0.4; patient 2 from 32.7 to 1.2 ; patient 3 from 7.6 to 0.6. Conclusions : The results suggest that Damwi-hwan can be an effective treatment for psoriasis who has lipid metabolic abnormality.

피부계 이상을 동반하는 선천성대사질환 (Congenital Metabolic Disorders with Cutaneous Changes)

  • 이상은
    • 대한유전성대사질환학회지
    • /
    • 제22권2호
    • /
    • pp.53-57
    • /
    • 2022
  • 다양한 아미노산 및 지질 대사 질환에서 피부와 모발의 변화가 관찰된다. 탈모증이 관찰되는 경우 장병성 선단피부염(아연 대사 장애), 비오티니다아제 결핍증 (비타민 B), 다발성 카르복실라제 결핍증, acrodermatitis acidemica 등 아미노산 및 비타민 대사 결함을 의심해볼 수 있다. 또한 부서지기 쉬운 모발이 관찰되는 경우 아르기니노숙신산뇨증 또는 시트룰린혈증 및 점액다당증을 의심해볼 수 있다. 건조하고 두꺼워진 인설을 가진 피부 또는 비늘증은 중성지질 축적 질환, 지방산 대사 장애, 콜레스테롤 합성 및 대사 장애와 관련하여 나타날 수 있다. 수포성 병변은 장병성 선단피부염, 비오티니다아제 결핍증, 홀로카르복실라제 합성효소 결핍증, acrodermatitis acidemica 등에서 나타날 수 있다.

건선의 치료 접근법에 대한 고찰 및 제언 (A Proposal and Considerations for Treatment Approaches of Psoriasis)

  • 강동원;한창이;김준동;김규석;김윤범
    • 한방안이비인후피부과학회지
    • /
    • 제33권3호
    • /
    • pp.99-114
    • /
    • 2020
  • Objectives : To investigate treatment approaches of psoriasis, and to provide universal and holistic standards to assist in optimizing patient care and future research. Methods : Review articles of psoriasis regarding pathophysiology, risk factor or treatment were searched from Pubmed (January 2016 to June 2020). Treatment approaches were investigated based on the searched articles. Additional data collecting was done for further discussion by searching Pubmed and Google scholar with keywords relevant to the approaches, and the relevant references of articles retrieved were manually inspected to be included. Results : Modalities to directly regulate the relevant helper T cell or inflammatory cytokines can constitute the treatment approaches of psoriasis. Modalities to treat gastrointestinal tract inflammation, to correct metabolic syndrome and to improve epidermal lipid abnormality via whole body lipid metabolism can also constitute the treatment approaches of psoriasis. Probable adverse effects of long term use of western medication should be addressed carefully, and alleviating the hazards of western medication can be a treatment approach of psoriasis. Conclusion : Treatment of psoriasis should take account of systemic aspects such as gastrointestinal tract and lipid metabolism. Treatment approaches of psoriasis established on the pathophysiological basis can serve as universal standards.

Characterization of Plasma Carnitine Level in Obese Adolescent Korean Women

  • Yoo, Hye-Hyun;Yoon, Ho-Joo;Shin, Hye-Jung;Lee, Sang-Hyup;Yoon, Hye-Ran
    • Biomolecules & Therapeutics
    • /
    • 제17권2호
    • /
    • pp.181-187
    • /
    • 2009
  • Carnitine is known to be involved in lipid metabolism and affects body composition as well as energy metabolism of the whole body. Improvement of obesity by L-carnitine supplement suggests that obesity can be related with the abnormality of carnitine metabolism and therefore, plasma carnitine level in normal and obesity groups was investigated. For the characterization of plasma carnitine level in obese people, 60 plasma samples collected from Korean women subjects were analyzed using LC/MS and plasma fatty acid level was also determined using GC/MS. Additionally, several clinical chemical parameters including fasting glucose, cholesterol, AST, and ALT level were measured. All the data obtained were combined and pattern recognition analysis was carried out with the dataset. Obese group showed a different metabolic pattern compared with normal group. Plasma acylcarnitine level of the obese group was found to be $11.7{\mu}g/ml$, which was higher than that of normal group ($8.0{\mu}g/ml$). Statistically significant differences in plasma fatty acid level were not observed between the two groups. Other clinical parameters for the obese group were within normal ranges but AST and ALT levels were slightly elevated compared to normal group. The obese group showed elevated plasma acylcarnitine level.